(Q35934700)

11 August 2017

1 reference

title

Autoantibodies to citrullinated (poly)peptides: a key diagnostic and prognostic marker for rheumatoid arthritis (English)

1 reference

11 August 2017

1 reference

1 reference

Albert J W Zendman

1

1 reference

PubMed ID

15518045

11 August 2017

Erik R Vossenaar

series ordinal

2

1 reference

PubMed ID

15518045

11 August 2017

Walther J van Venrooij

series ordinal

3

1 reference

11 August 2017

1 June 2004

1 reference

11 August 2017

1 reference

11 August 2017

37

1 reference

11 August 2017

4

1 reference

11 August 2017

295-299

1 reference

Therapeutic strategies for rheumatoid arthritis

11 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F08916930410001708733

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930410001708733

Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930410001708733

PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930410001708733

A NEW SERUM FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS; THE ANTIPERINUCLEAR FACTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930410001708733

Anti-keratin antibodies in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930410001708733

The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930410001708733

Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930410001708733

Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930410001708733

Autoantibodies recognizing citrullinated rat filaggrin in an ELISA using citrullinated and non-citrullinated recombinant proteins as antigens are highly diagnostic for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930410001708733

The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930410001708733

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930410001708733

High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930410001708733

Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930410001708733

Clinical utility of the anti-CCP assay in patients with rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930410001708733

Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930410001708733

Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930410001708733

Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930410001708733

The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930410001708733

Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930410001708733

Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930410001708733

Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930410001708733

Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930410001708733

Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930410001708733

How to diagnose rheumatoid arthritis early: A prediction model for persistent (erosive) arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930410001708733

10.1080/08916930410001708733

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference

PubMed ID

15518045